Randall Kaye
Chief Tech/Sci/R&D Officer presso LONGBOARD PHARMACEUTICALS, INC.
Patrimonio netto: 403 172 $ in data 31/03/2024
Profilo
Randall E.
Kaye is currently the Director at NervGen Pharma Corp.
and the Chief Medical Officer & EVP at Longboard Pharmaceuticals, Inc. He previously worked as the Vice President-Medical Affairs at Scios, Inc. from 2004 to 2006, and as the Chief Medical Officer & SVP-Medical Affairs at Avanir Pharmaceuticals, Inc. from 2006 to 2014.
He also served as the Vice President-Medical Affairs at InterMune, Inc. and as the Chief Medical Officer at Axsome Therapeutics, Inc. from 2014 to 2016.
Additionally, he was the Chief Medical Officer at Click Therapeutics, Inc. from 2018 to 2019 and the Chief Scientific Officer at SSI Strategy LLC from 2014 to 2018.
He has also worked as the Chief Medical Officer at Neurana Pharmaceuticals, Inc. Dr. Kaye received his undergraduate, graduate, and doctorate degrees from George Washington University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 08/02/2024 | 17 920 ( 0.05% ) | 387 072 $ | 31/03/2024 | |
NERVGEN PHARMA CORP.
0.02% | 28/03/2024 | 10 000 ( 0.02% ) | 16 100 $ | 31/03/2024 |
Posizioni attive di Randall Kaye
| Società | Posizione | Inizio |
|---|---|---|
| NERVGEN PHARMA CORP. | Director/Board Member | 28/10/2020 |
| LONGBOARD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 21/03/2022 |
Precedenti posizioni note di Randall Kaye
| Società | Posizione | Fine |
|---|---|---|
Click Therapeutics, Inc.
 Click Therapeutics, Inc. Packaged SoftwareTechnology Services Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. The company is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | 01/09/2019 |
SSI Strategy LLC
 SSI Strategy LLC Miscellaneous Commercial ServicesCommercial Services SSI Strategy owns and operates boutique management consulting firm. Its services include global medical affairs transformation, competency model development, post-merger integration, launch preparation, emerging markets medical affairs: organizational transformation, pharmacovigilance system enhancement and medical planning and tactic prioritization. The company was founded by Gregory Fiore in 2010 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | 01/09/2018 |
| AXSOME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2016 |
| AVANIR PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 01/09/2014 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Chief Tech/Sci/R&D Officer | 01/01/2006 |
Formazione di Randall Kaye
| George Washington University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| AXSOME THERAPEUTICS, INC. | Health Technology |
| NERVGEN PHARMA CORP. | Health Technology |
| LONGBOARD PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Click Therapeutics, Inc.
Click Therapeutics, Inc. Packaged SoftwareTechnology Services Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. The company is headquartered in New York, NY. | Technology Services |
SSI Strategy LLC
SSI Strategy LLC Miscellaneous Commercial ServicesCommercial Services SSI Strategy owns and operates boutique management consulting firm. Its services include global medical affairs transformation, competency model development, post-merger integration, launch preparation, emerging markets medical affairs: organizational transformation, pharmacovigilance system enhancement and medical planning and tactic prioritization. The company was founded by Gregory Fiore in 2010 and is headquartered in Parsippany, NJ. | Commercial Services |
Neurana Pharmaceuticals, Inc.
 Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurana Pharmaceuticals, Inc. engages in a biotechnology industry. It focused on the development of drugs to treat neuromuscular disorders. The company was founded in 2013 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Randall Kaye
